TDX20 represents a new generation of transdermal delivery technology.
It achieves up to 20x higher penetration of active ingredients through in situ encapsulation powered by Genosome technology.
TDX20
A Breakthrough in Transdermal Delivery
TDX20 represents a new generation of transdermal delivery technology.
It achieves up to 20x higher penetration of active ingredients through in situ encapsulation powered by Genosome technology.
This is not a conventional carrier system.
It is a platform built for precision, personalization, and potency.
The Scientific Challenge
Human skin is not passive. It is a highly selective biological barrier.
The outermost layer, the stratum corneum, is specifically designed to prevent the entry of most molecules — especially those that are:
-
Large
-
Polar
-
Chemically unstable
There is also the well-known “500 Dalton rule”:
Molecules larger than 500 Daltons rarely penetrate the skin through passive diffusion.
This limitation significantly reduces the effectiveness of many advanced actives, particularly:
-
Peptides
-
Antioxidants
-
Growth factors
In short, many powerful ingredients never truly reach their biological target.
The TDX20 Solution: Real-Time Encapsulation
TDX20 introduces a fundamentally different approach.
Instead of forcing actives through the barrier, it creates ultraflexible lipid vesicles capable of adapting to the microstructure of the skin.
The critical innovation:
Encapsulation occurs in situ, immediately before application.
Through a controlled mechanical stress process — involving centrifugation and agitation — the system generates freshly formed, highly efficient vesicles that:
-
Encapsulate actives in real time
-
Stabilize sensitive molecules
-
Dramatically enhance transdermal absorption
The result is up to 20x increased penetration compared to conventional topical systems.
A Modular, Intelligent Platform
TDX20 is not a single product. It is a modular delivery platform.
It allows:
-
Customization of active ingredients
-
Fresh activation prior to use
-
Clinical optimization depending on indication
This makes it particularly suited for:
-
Intelligent beauty protocols
-
Skin longevity strategies
-
Regenerative dermatology
-
Advanced aesthetic science
What This Actually Changes
Traditional topical systems follow this pattern:
Pre-formulated product → gradual degradation → limited penetration.
TDX20 changes the model to:
Fresh activation → real-time encapsulation → targeted deep absorption.
In practical terms, this moves skincare from passive application to programmable dermal delivery.
That shift is not incremental. It is structural.